Immune responses to adeno-associated virus type 2 encoding channelrhodopsin-2 in a genetically blind rat model for gene therapy.
about
Optogenetic approaches to retinal prosthesisBiophysical Properties of Optogenetic Tools and Their Application for Vision Restoration ApproachesRestoration of the majority of the visual spectrum by using modified Volvox channelrhodopsin-1.Optogenetically induced seizure and the longitudinal hippocampal network dynamicsEstablishment of monocular-limited photoreceptor degeneration models in rabbits.Optical control after transfection of channelrhodopsin-2 recombinant adenovirus in visual cortical cellsOptogenetics: a novel optical manipulation tool for medical investigation.Proceedings of the First International Optogenetic Therapies for Vision Symposium.Channelrhodopsins: visual regeneration and neural activation by a light switch.Beyond the brain: Optogenetic control in the spinal cord and peripheral nervous system.A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina.Long-term expression of melanopsin and channelrhodopsin causes no gross alterations in the dystrophic dog retina.Visual Responses of Photoreceptor-Degenerated Rats Expressing Two Different Types of Channelrhodopsin Genes.Local and systemic responses following intravitreous injection of AAV2-encoded modified Volvox channelrhodopsin-1 in a genetically blind rat model.A Chronically Implantable Bidirectional Neural Interface for Non-human PrimatesCardiac optogenetics: the next frontier.Optogenetic Peripheral Nerve ImmunogenicityOptogenetic Light Sensors in Human Retinal Organoids
P2860
Q27009269-B2F7DA85-F186-4EF7-B224-8DCA6FF874BCQ28066510-3B64CF3D-194D-41D3-AC43-9225A116346FQ30650951-B22D2267-19B3-4D8F-A670-45A717FE34D2Q34674356-4BEEBA64-27E3-49FD-BA34-1DAC8BC02631Q34727400-1FD73E96-7F34-4494-B84B-D90248ECC4F8Q35109278-555CCDC9-43C4-4B6D-8A7C-90895C2E737AQ36192198-9832F0E5-3C3B-47E5-9E61-69808A906888Q37386268-8CAFEB09-72F1-4D77-854E-0521F5EB3D48Q38105796-224C7F6D-6058-4F50-8B68-44F655FB806CQ38826202-7DADBA56-0E52-420C-94EF-B9CD31B1DF59Q38936694-8137C855-C46D-4A60-8FE7-06CDCC429187Q40054094-6FF2534E-57BE-484F-A0D1-F44C3C7630C1Q40368789-02389E34-CF19-44DB-8D9D-5F1ACFBF63ACQ41258331-9DEC2220-63AE-4196-9EB2-C232A6804CDFQ41665361-6CB26891-6E83-4933-8CD2-DCEEBCA8FF7BQ47743636-61BE7516-DCA2-4235-9FDA-1B2410726476Q57155098-1F3F77CC-024E-45FA-BCAE-B16C10B3A7ADQ59137485-0D4E0D85-832D-4AC9-A3C5-3AE1B9A096B5
P2860
Immune responses to adeno-associated virus type 2 encoding channelrhodopsin-2 in a genetically blind rat model for gene therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Immune responses to adeno-asso ...... nd rat model for gene therapy.
@en
Immune responses to adeno-asso ...... nd rat model for gene therapy.
@nl
type
label
Immune responses to adeno-asso ...... nd rat model for gene therapy.
@en
Immune responses to adeno-asso ...... nd rat model for gene therapy.
@nl
prefLabel
Immune responses to adeno-asso ...... nd rat model for gene therapy.
@en
Immune responses to adeno-asso ...... nd rat model for gene therapy.
@nl
P2093
P2860
P356
P1433
P1476
Immune responses to adeno-asso ...... nd rat model for gene therapy.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2010.140
P577
2010-10-28T00:00:00Z
P6179
1026972595